Gino A Kurian Selected Research

fisetin

7/2022	Recent advances in potential of Fisetin in the management of myocardial ischemia-reperfusion injury-A systematic review.
3/2022	FIsetin Preserves Interfibrillar Mitochondria to Protect Against Myocardial Ischemia-Reperfusion Injury.
1/2022	Fisetin attenuates renal ischemia/reperfusion injury by improving mitochondrial quality, reducing apoptosis and oxidative stress.
1/2022	Long-term administration of fisetin was not as effective as short term in ameliorating IR injury in isolated rat heart.
11/2021	PM2.5 from diesel exhaust attenuated fisetin mediated cytoprotection in H9c2 cardiomyocytes subjected to ischemia reoxygenation by inducing mitotoxicity.
1/2021	Fisetin Attenuates Myocardial Ischemia-Reperfusion Injury by Activating the Reperfusion Injury Salvage Kinase (RISK) Signaling Pathway.
1/2018	Fisetin Confers Cardioprotection against Myocardial Ischemia Reperfusion Injury by Suppressing Mitochondrial Oxidative Stress and Mitochondrial Dysfunction and Inhibiting Glycogen Synthase Kinase 3β Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gino A Kurian Research Topics

Disease

29	Reperfusion Injury 09/2022 - 04/2008
21	Ischemia 09/2022 - 08/2008
16	Myocardial Ischemia (Ischemic Heart Diseases) 09/2022 - 01/2010
14	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 04/2008
11	Infarction (Infarctions) 03/2022 - 07/2016
7	Vascular Calcification 04/2018 - 11/2015
5	Myocardial Infarction 01/2022 - 12/2020
4	Renal Insufficiency (Renal Failure) 10/2017 - 11/2016
3	Diabetic Cardiomyopathies 01/2022 - 03/2019
3	Body Weight (Weight, Body) 01/2022 - 01/2010
3	Diabetes Mellitus 01/2020 - 01/2019
3	Urolithiasis 12/2017 - 05/2015
3	Myocardial Reperfusion Injury 08/2017 - 05/2016
2	Neoplasms (Cancer) 07/2022 - 12/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2018 - 01/2018
1	Obesity 07/2022
1	Cardiotoxicity 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 12/2021
1	Muscular Diseases (Myopathy) 01/2020
1	Cognitive Dysfunction 01/2019
1	Heart Failure 06/2018
1	Rupture 06/2018
1	Atherosclerotic Plaque (Atheroma) 06/2018
1	Noncommunicable Diseases 06/2018
1	Calciphylaxis 04/2018
1	Chronic Renal Insufficiency 04/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2017
1	Cardiac Arrhythmias (Arrythmia) 08/2017
1	Atherosclerosis 08/2017
1	Hypoxia (Hypoxemia) 07/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017

Drug/Important Bio-Agent (IBA)

12	sodium thiosulfate FDA Link 06/2021 - 11/2015
10	EnzymesIBA 01/2022 - 04/2008
9	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2022 - 01/2010
8	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022 - 05/2016
7	AntioxidantsIBA 09/2022 - 02/2009
7	fisetinIBA 07/2022 - 01/2018
7	Adenosine Triphosphate (ATP)IBA 04/2020 - 07/2014
6	Creatine Kinase (Creatine Phosphokinase)IBA 03/2022 - 07/2016
6	CalciumIBA 03/2019 - 11/2015
6	Adenine FDA LinkGeneric 04/2018 - 11/2015
3	FlavonoidsIBA 07/2022 - 01/2018
3	Particulate MatterIBA 01/2022 - 11/2021
3	Vehicle Emissions (Emissions, Vehicle)IBA 01/2022 - 11/2021
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2022 - 12/2020
3	Streptozocin (Streptozotocin)FDA Link 01/2020 - 01/2019
2	Glycogen Synthase KinasesIBA 03/2022 - 01/2018
2	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 12/2021
2	sodium bisulfide (NaHS)IBA 01/2020 - 01/2020
2	Free RadicalsIBA 03/2019 - 08/2017
2	CytokinesIBA 08/2017 - 07/2014
2	Potassium Channels (Potassium Channel)IBA 01/2017 - 07/2016
2	Nicorandil (SG 75)IBA 01/2017 - 01/2017
2	Malondialdehyde (Propanedial)IBA 11/2016 - 01/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2014 - 04/2008
1	ResveratrolIBA 09/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2022
1	3-hydroxyflavoneIBA 03/2022
1	PhytochemicalsIBA 03/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	calcium phosphateIBA 12/2021
1	Cardiotonic Agents (Cardiac Stimulants)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	tricarbonyldichlororuthenium (II) dimerIBA 10/2021
1	Carbon MonoxideIBA 10/2021
1	GasotransmittersIBA 10/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 06/2021
1	Glyburide (Glibenclamide)FDA LinkGeneric 06/2021
1	WortmanninIBA 06/2021
1	Sirolimus (Rapamycin)FDA Link 06/2021
1	KATP ChannelsIBA 06/2021
1	SodiumIBA 06/2021
1	BuffersIBA 06/2021
1	N- succinimidyl- 5- iodo- 3- pyridinecarboxylic acidIBA 06/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	MM Form Creatine KinaseIBA 12/2020
1	Nootropic Agents (Nootropics)IBA 12/2020
1	CaspasesIBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 03/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 06/2018
1	Mitochondrial DNA (mtDNA)IBA 06/2018
1	Air Pollutants (Pollutants, Air)IBA 06/2018
1	Oxidants (Oxidizing Agents)IBA 06/2018
1	Cyanides (Isocyanides)IBA 10/2017
1	5'-Nucleotidase (5' Nucleotidase)IBA 10/2017
1	AntidotesIBA 10/2017
1	Adenosine Triphosphatases (ATPase)IBA 10/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2017
1	Phospholipases (Phospholipase)IBA 08/2017
1	ChemokinesIBA 08/2017
1	Secretory Phospholipases A2IBA 08/2017
1	NitrogenIBA 07/2017
1	Phosphorus (Red Phosphorus)IBA 01/2017
1	Adenosine Diphosphate (ADP)IBA 01/2017

Therapy/Procedure

1	Ligation 12/2021
1	Therapeutics 10/2017